Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Net Cash Flow (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Net Cash Flow data on record, last reported at -$1.2 million in Q4 2024.

  • For Q4 2024, Net Cash Flow rose 95.6% year-over-year to -$1.2 million; the TTM value through Dec 2024 reached $701000.0, down 99.07%, while the annual FY2025 figure was -$40.8 million, 5922.97% down from the prior year.
  • Net Cash Flow reached -$1.2 million in Q4 2024 per SGMT's latest filing, up from -$18.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $101.6 million in Q1 2024 and bottomed at -$80.8 million in Q2 2024.